Evidence map›Paper›PMID 26757165›Full record

ArticleCritical care medicine2016

Complement Factor B Production in Renal Tubular Cells and Its Role in Sodium Transporter Expression During Polymicrobial Sepsis.

Dan Li, Lin Zou, Yan Feng, Ganqiong Xu, Yu Gong, Gaofeng Zhao, Wen Ouyang, Joshua M Thurman, Wei Chao

Open access · greenAbstract read
In one paragraph

Article in Critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The complement system in pediatric acute kidney injury.Pediatric nephrology (Berlin, Germany) · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Subcutaneous administration of β-hydroxybutyrate improves learning and memory of sepsis surviving mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Dan Li1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 2Department of Anesthesia, the Third Xiangya Hospital, Xiangya School of Medicine, Changsha, China. 3Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 4Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
Lin Zou
Yan Feng
Ganqiong Xu
Yu Gong
Gaofeng Zhao
Wen Ouyang
Joshua M Thurman
Wei Chao
Massachusetts General Hospital · US

Funding

The Complement System and Ischemic Acute Renal FailureR01DK076690 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Joshua M Thurman · 2008 to 2026
$6.6M
Role of TLR-cfB Signaling in SepsisR01GM097259 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI CHAO, WEI · 2012 to 2015
$1.9M
NIDDK NIH HHS DK076690NIDDK NIH HHS R01 DK076690NIGMS NIH HHS GM097259NIGMS NIH HHS R01 GM097259
6 · The paper itself

Abstract

objectivesToll-like receptors and complement are two components of the innate immunity. Complement factor B is essential for the alternative pathway of complement activation. We have recently reported that complement factor B is significantly up-regulated in the kidney and may contribute to acute tubular injury in an animal model of sepsis. This study investigates the mechanisms responsible for the complement factor B up-regulation and its role in sodium transporter expression in tubular cells during sepsis.

designAnimal study.

settingLaboratory investigation. SUBJECTS: C57BL/6 J wild-type, complement factor B(-/-), and Nfkb1(tm1Bal) p50(-/-) mice.

interventionsHuman proximal tubular cells and mouse tubular epithelial cells were stimulated with Toll-like receptor agonists. Bay 11-7082 was used to block nuclear factor-κB pathway. Alternative pathway activation was detected by C3 zymosan deposition. Polymicrobial sepsis was created by cecal ligation and puncture. Sodium transporter gene expression was determined by quantitative reverse transcriptase-polymerase chain reaction. MEASUREMENTS AND MAIN

resultsThe agonists for Toll-like receptor 4 (lipopolysaccharide) or Toll-like receptor 3 (polyinosinic-polycytidylic acid) induced a marked increase in complement factor B expression in human proximal tubular cells and mouse tubular epithelial cells both at gene and protein levels. The Toll-like receptor 1/2 agonist, Pam3cys, induced complement factor B production only in human proximal tubular cells, not in mouse tubular epithelial cells. The Toll-like receptor 9 ligand, CpG oligodeoxynucleotides failed to induce complement factor B production either in human proximal tubular cells or in mouse tubular epithelial cells. Lipopolysaccharide/polyinosinic-polycytidylic acid-induced complement factor B up-regulation was blocked by Bay 11-7082, a potent inhibitor of nuclear factor-κB signaling, and in mouse tubular epithelial cells deficient in p50 subunit of nuclear factor-κB. Media from the lipopolysaccharide-treated mouse tubular epithelial cell cultures contained de novo synthesized complement factor B and led to functional alternative pathway activation. In a cecal ligation and puncture model, wild-type septic mice had down-regulated expression of sodium transporters in the kidney compared with the sham. In comparison, complement factor B mice or mice treated with anti-complement factor B displayed preserved levels of Na⁺/K⁺ ATPase-α1 following sepsis.

conclusions1) Toll-like receptor 3/4 activation is sufficient to induce complement factor B production via nuclear factor-κB pathway and to enhance alternative pathway activation in the kidney tubular epithelial cells. 2) Complement factor B may contribute to the down-regulation of certain sodium transporter expression during sepsis.

Indexed as

AnimalsBiological Transport, ActiveComplement Factor BDisease Models, AnimalDown-RegulationEpithelial Sodium ChannelsFemaleGene ExpressionHumansKidneyKidney Tubules, ProximalMaleMiceMice, Inbred C57BLNF-kappa BNitriles3-(4-methylphenylsulfonyl)-2-propenenitrileComplement Factor BEpithelial Sodium ChannelsNF-kappa BNitrilesPotassium ChannelsSulfonesToll-Like Receptors

Identifiers

PMID26757165
PMCPMC4833616
OpenAlexW2317168190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.